Mindfulness-Based Nursing Intervention for Anxiety and Quality of Life in Palliative Cancer Care: A Quasi-Experimental Study
Journal of Health and Nutrition Research August 1, 2026 DOI: 10.56303/jhnresearch.v5i2.1530 (opens in new tab)
Study at a glance
AI-extracted from the abstract| Characteristics | Quasi-experimental study Peer reviewed |
|---|---|
| Population | Advanced cancer patients in palliative care, predominantly female (60.0%), with stage IV malignancies (63.3%) and lung cancer as the most frequent primary site (30.0%) |
| Intervention | Mindfulness-Based Nursing Intervention (MBNI) |
| Measures | Hospital Anxiety and Depression Scale (HADS-A), EORTC QLQ-C30 Global Health Status scale |
| Topics | Anxiety End-of-life distress Meditation |
| Key findings | MBNI significantly reduced anxiety (mean HADS-A score from 20.0 to 14.0) and improved quality of life (mean EORTC QLQ-C30 score from 50.0 to 65.0), both with p < 0.001 and a large adjusted effect size (dav = 1.20). |
Abstract
Advanced cancer patients in palliative care frequently face severe existential anxiety and diminished quality of life (QoL). While managing this psychological distress is critical, pharmacological interventions often present adverse side effects. This quasi-experimental study aimed to evaluate the effectiveness of a structured Mindfulness-Based Nursing Intervention (MBNI) on anxiety levels and QoL among patients receiving palliative cancer care. The study evaluated anxiety using the Hospital Anxiety and Depression Scale (HADS-A) and QoL via the EORTC QLQ-C30 Global Health Status scale. The participant cohort predominantly consisted of females (60.0%) and individuals diagnosed with stage IV malignancies (63.3%), with lung cancer being the most frequent primary site (30.0%). Data were analyzed utilizing the non-parametric Wilcoxon signed-rank test. To prevent inflation and account for paired data, clinical effect sizes were calculated using the standardized mean difference adjusted for paired variances (dav). Following MBNI implementation, participants demonstrated statistically significant improvements across both primary endpoints (p < 0.001). The mean anxiety score notably decreased from a baseline of 20.0 ± 5.0 to 14.0 (Z = -4.512). Concurrently, the mean QoL score increased substantially from 50.0 ± 12.5 to 65.0 (Z = -4.287). The intervention produced a large, identical adjusted effect size of dav = 1.20 for both anxiety reduction and QoL enhancement. The MBNI represents a highly promising, non-pharmacological modality for mitigating severe psychological distress and optimizing global well-being. Integrating this structured protocol into holistic palliative nursing pathways is strongly recommended to ground fragile oncology patients amidst prognostic uncertainty.